Intensive Prevention Program After Decompensated Heart Failure

Recruiting N/A Interventional Study
Heart Failure
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
200 (estimated)
Sponsor
Herzzentrum Bremen · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Introduction: Care for patients with heart failure (HF) often remains inadequate, even though a variety of treatment options exist. Guideline-based, multimodal therapy is rarely fully established, partly due to insufficient intersectoral cooperation and insufficient patient training. Heart failure nurses (HFN) as specialized non-medical personnel are intended to contribute to better patient care. …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Hospitalization due to symptomatic HF NYHA II-IV, defined according to valid international guidelines, including signs of congestion, ejection fraction ≤40%, elevated NTproBNP * Age 18 - 80 years * Life expectancy \> 2 years * Access to internet, physical and mental ability an…
Contacts

Stephan Ruehle

+494218794684

stephan.ruehle@gesundheitnord.de

CONTACT

Harm Wienbergen

+494218794059

harm.wienbergen@gesundheitnord.de

CONTACT